Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $2.9 Million - $3.87 Million
-20,584 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $2.94 Million - $4.71 Million
-18,264 Reduced 47.01%
20,584 $3.87 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $553,116 - $680,185
-2,234 Reduced 5.44%
38,848 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $247,357 - $411,746
-1,270 Reduced 3.0%
41,082 $11.9 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $15 Million - $20 Million
-90,554 Reduced 68.13%
42,352 $8.45 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $7,214 - $9,050
-40 Reduced 0.03%
132,906 $25.8 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $3.19 Million - $4.46 Million
-21,567 Reduced 13.96%
132,946 $25.5 Million
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $2.71 Million - $3.51 Million
22,149 Added 16.73%
154,513 $22.8 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $4.41 Million - $6.56 Million
46,715 Added 54.54%
132,364 $16.4 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $134,831 - $173,205
-1,587 Reduced 1.82%
85,649 $8.27 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $434,031 - $547,124
-5,878 Reduced 6.31%
87,236 $8.07 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $15,100 - $18,815
197 Added 0.21%
93,114 $7.14 Million
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $2.55 Million - $3.21 Million
54,393 Added 141.19%
92,917 $5.15 Million
Q2 2018

Aug 14, 2018

SELL
$35.26 - $47.04 $5,253 - $7,008
-149 Reduced 0.39%
38,524 $1.81 Million
Q1 2018

May 15, 2018

SELL
$30.92 - $37.27 $44,586 - $53,743
-1,442 Reduced 3.59%
38,673 $1.4 Million
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $11,580 - $13,855
-356 Reduced 0.88%
40,115 $1.46 Million
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $1.5 Million - $1.86 Million
40,471
40,471 $1.55 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.75B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.